Patient-specific decision modeling to guide the use of drotrecogin α (activated) in patients with severe sepsis

A customizable decision model using patient-specific inputs can be used to inform the treatment decision when considering the use of drotrecogin α (activated) therapy by weighing the risks vs the benefits of therapy in the treatment of severe sepsis.